Regentis Biomaterials Stock Forecast
NYSE: RGNTHealth CareIndustrial SpecialtiesUSD
Market open · Delayed 15 min · as of Oct 9, 9:46 AM ET
RGNT analyst consensus
Consensus
none
Avg. price target
$10.00+498.80%
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
The average 12-month price target is $10.00, with a high estimate of $10.00 and a low estimate of $10.00. The average target implies upside of 498.8% from the current price of $1.67. The spread between the highest and lowest targets is 0.0%, a relatively narrow range.
Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for RGNT.
Summary generated from market data by MetaCap's automated system. Methodology
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $10.00 | +498.80% |
| Average target | $10.00 | +498.80% |
| High target | $10.00 | +498.80% |